Treace Medical Concepts (TMCI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $4.12, +1.98% vs the prior close of $4.04.
- Volume 261.90K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TMCI rises 2.0% to $4.12. Closed at $4.12, +1.98% vs the prior close of $4.04. Day range $4.04–$4.21, opened at $4.04.
TMCI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TMCI rises 2.0% to $4.12
- Closed at $4.12, +1.98% vs the prior close of $4.04. Day range $4.04–$4.21, opened at $4.04.
- Volume was 261.90K shares, 0.9x its 50-day average of 300.55K.
- Price is -8.0% vs its 50-day average ($4.48) and +31.0% vs its 200-day average ($3.15).
- 52-week range $1.17–$7.08; today's close sits at 50% of that range, 41.8% below the 52-week high.
Oct 14, 2026 — TMCI dips 1.5% to $4.04
- Closed at $4.04, -1.46% vs the prior close of $4.10. Day range $4.02–$4.21, opened at $4.05.
- Volume was 220.30K shares, 0.7x its 50-day average of 301.87K.
- Price is -10.1% vs its 50-day average ($4.49) and +28.7% vs its 200-day average ($3.14).
- 52-week range $1.17–$7.08; today's close sits at 49% of that range, 42.9% below the 52-week high.
Oct 13, 2026 — TMCI ends flat (+0.0%) to $4.10
- Closed at $4.10, +0.00% vs the prior close of $4.10. Day range $4.05–$4.16, opened at $4.10.
- Volume was 112.20K shares, 0.4x its 50-day average of 307.11K — lighter than usual.
- Price is -9.0% vs its 50-day average ($4.51) and +31.0% vs its 200-day average ($3.13).
- 52-week range $1.17–$7.08; today's close sits at 50% of that range, 42.1% below the 52-week high.
Oct 12, 2026 — TMCI jumps 3.8% to $4.10
- Closed at $4.10, +3.80% vs the prior close of $3.95. Day range $3.92–$4.15, opened at $3.95.
- Volume was 124.30K shares, 0.4x its 50-day average of 308.79K — lighter than usual.
- Price is -9.3% vs its 50-day average ($4.52) and +31.3% vs its 200-day average ($3.12).
- 52-week range $1.17–$7.08; today's close sits at 50% of that range, 42.1% below the 52-week high.
Oct 9, 2026 — TMCI rises 1.9% to $3.95
- Closed at $3.95, +1.94% vs the prior close of $3.88. Day range $3.84–$4.07, opened at $3.88.
- Volume was 161.20K shares, 0.5x its 50-day average of 311.35K — lighter than usual.
- Price is -12.7% vs its 50-day average ($4.52) and +26.9% vs its 200-day average ($3.11).
- 52-week range $1.17–$7.08; today's close sits at 47% of that range, 44.2% below the 52-week high.
Oct 8, 2026 — TMCI dips 0.4% to $3.88, a 3-month low, 3 down days in a row
- Closed at $3.88, -0.39% vs the prior close of $3.89. Day range $3.78–$3.92, opened at $3.87.
- Volume was 233.80K shares, 0.7x its 50-day average of 315.31K.
- Price is -14.5% vs its 50-day average ($4.53) and +24.8% vs its 200-day average ($3.11).
- 52-week range $1.17–$7.08; today's close sits at 46% of that range, 45.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — TMCI dips 2.7% to $3.89, a 3-month low
- Closed at $3.89, -2.75% vs the prior close of $4.00. Day range $3.82–$4.12, opened at $3.98.
- Volume was 250.40K shares, 0.8x its 50-day average of 317.85K.
- Price is -14.2% vs its 50-day average ($4.53) and +25.5% vs its 200-day average ($3.10).
- 52-week range $1.17–$7.08; today's close sits at 46% of that range, 45.1% below the 52-week high.
Oct 6, 2026 — TMCI slides 10.7% to $4.00, a 1-month low on 2.1x normal volume
- Closed at $4.00, -10.71% vs the prior close of $4.48. Day range $3.98–$4.53, opened at $4.53.
- Volume was 652.00K shares, 2.1x its 50-day average of 309.57K — unusually heavy trading.
- Price is -11.8% vs its 50-day average ($4.54) and +29.4% vs its 200-day average ($3.09).
- 52-week range $1.17–$7.08; today's close sits at 48% of that range, 43.5% below the 52-week high.
Oct 5, 2026 — TMCI rises 2.1% to $4.48
- Closed at $4.48, +2.05% vs the prior close of $4.39. Day range $4.24–$4.54, opened at $4.40.
- Volume was 210.70K shares, 0.7x its 50-day average of 310.20K.
- Price is -1.3% vs its 50-day average ($4.54) and +45.2% vs its 200-day average ($3.08).
- 52-week range $1.17–$7.08; today's close sits at 56% of that range, 36.7% below the 52-week high.
Oct 2, 2026 — TMCI rises 1.4% to $4.39
- Closed at $4.39, +1.39% vs the prior close of $4.33. Day range $4.22–$4.41, opened at $4.37.
- Volume was 154.70K shares, 0.5x its 50-day average of 312.56K — lighter than usual.
- Price is -3.1% vs its 50-day average ($4.53) and +42.7% vs its 200-day average ($3.08).
- 52-week range $1.17–$7.08; today's close sits at 54% of that range, 38.0% below the 52-week high.
TMCI latest news & SEC filings
Every SEC filing by or about TMCI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Elder Scot Michael had withheld for taxes 25,457 shares on Sep 30, 2026; now holds 753,226
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Treace John T. bought 11,000 shares at $4.34 (≈$47.74K) on Aug 24, 2026
- Treace John T. bought 5,000 shares at $4.35 (≈$21.75K) on Aug 21, 2026
- Treace John T. bought 39,944 shares at $4.44 (≈$177.35K) on Aug 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $45.38M (prior year $47.39M) (-4.2% vs Jun 30, 2025)
- Net income: -$15.87M (prior year -$17.40M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.24 (prior year -$0.28) (loss narrowed vs Jun 30, 2025)
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 30, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade TMCI
- Last results release: Aug 7, 2026 (8-K Item 2.02). Previous ones: May 8, 2026, Apr 9, 2026, Feb 27, 2026. Based on that rhythm, the next report is likely around Nov 6, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.16% (largest 10.7%).
- Liquidity: about 238.32K shares (≈$981.90K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.12 vs a range of $1.17–$7.08 (50% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 14 open-market buys, 0 sales; latest: John T. Treace bought 11,000 shares on Aug 24, 2026.
- Latest filings: 10-Q Aug 7, 2026; 8-K Aug 7, 2026; 8-K May 20, 2026.
- Share count: 65.03M shares outstanding (Jul 31, 2026), +2.9% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
TMCI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 4.04 | 4.21 | 4.04 | 4.12 | 261.90K |
| Oct 14, 2026 | 4.05 | 4.21 | 4.02 | 4.04 | 220.30K |
| Oct 13, 2026 | 4.10 | 4.16 | 4.05 | 4.10 | 112.20K |
| Oct 12, 2026 | 3.95 | 4.15 | 3.92 | 4.10 | 124.30K |
| Oct 9, 2026 | 3.88 | 4.07 | 3.84 | 3.95 | 161.20K |
| Oct 8, 2026 | 3.87 | 3.92 | 3.78 | 3.88 | 233.80K |
| Oct 7, 2026 | 3.98 | 4.12 | 3.82 | 3.89 | 250.40K |
| Oct 6, 2026 | 4.53 | 4.53 | 3.98 | 4.00 | 652.00K |
| Oct 5, 2026 | 4.40 | 4.54 | 4.24 | 4.48 | 210.70K |
| Oct 2, 2026 | 4.37 | 4.41 | 4.22 | 4.39 | 154.70K |
| Oct 1, 2026 | 4.42 | 4.44 | 4.26 | 4.33 | 183.10K |
| Sep 30, 2026 | 4.62 | 4.62 | 4.43 | 4.44 | 157.60K |
| Sep 29, 2026 | 4.48 | 4.63 | 4.41 | 4.62 | 141.70K |
| Sep 28, 2026 | 4.49 | 4.50 | 4.39 | 4.48 | 169.60K |
| Sep 25, 2026 | 4.55 | 4.64 | 4.44 | 4.50 | 210.50K |
| Sep 24, 2026 | 4.51 | 4.62 | 4.41 | 4.54 | 148.10K |
| Sep 23, 2026 | 4.56 | 4.67 | 4.41 | 4.51 | 318.00K |
| Sep 22, 2026 | 4.48 | 4.67 | 4.45 | 4.59 | 396.00K |
| Sep 21, 2026 | 4.54 | 4.54 | 4.38 | 4.48 | 316.70K |
| Sep 18, 2026 | 4.57 | 4.68 | 4.47 | 4.49 | 343.70K |
About Treace Medical Concepts
Treace Medical Concepts (TMCI) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in PONTE VEDRA, FL. State of incorporation: FL. Fiscal year ends December 31. SEC CIK 1630627.
TMCI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John K Bakewell | Director | May 19, 2026 |
| Lance A Berry | Director | May 19, 2026 |
| Lawrence W Hamilton | Director | May 19, 2026 |
| Betsy Hanna | Director | May 19, 2026 |
| Deepti Jain | Director | May 19, 2026 |
| Jane E Kiernan | Director | May 19, 2026 |
| John T. Treace | Chief Executive Officer | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Scot Michael Elder | Chief Legl & Comp Off, CorpSec | Aug 12, 2026 |
| Gaetano Guglielmino | Chief Commercial Officer | Jan 23, 2026 |
| Guy Guglielmino | Chief Commercial Officer | Dec 3, 2025 |
| Mark Hair | Chief Financial Officer | Aug 12, 2026 |
| Sean F. Scanlan | Chief Innovation Officer | Aug 12, 2026 |
| John T. Treace | Chief Executive Officer | Aug 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | John T. Treace | Buy | 11,000 | $4.34 |
| Aug 21, 2026 | John T. Treace | Buy | 5,000 | $4.35 |
| Aug 20, 2026 | John T. Treace | Buy | 39,944 | $4.44 |
| Jun 11, 2026 | John T. Treace | Buy | 9,891 | $4.04 |
| Jun 11, 2026 | John T. Treace | Buy | 22,887 | $4.04 |
| Jun 10, 2026 | John T. Treace | Buy | 14,715 | $4.02 |
| Jun 10, 2026 | John T. Treace | Buy | 29,430 | $4.02 |
| Jun 1, 2026 | John T. Treace | Buy | 50,000 | $3.56 |
| May 28, 2026 | John T. Treace | Buy | 61,202 | $3.02 |
| May 27, 2026 | John T. Treace | Buy | 49,810 | $2.87 |
| May 26, 2026 | John T. Treace | Buy | 4,508 | $2.79 |
| May 14, 2026 | John T. Treace | Buy | 61,750 | $2.62 |
| May 13, 2026 | John T. Treace | Buy | 49,013 | $2.46 |
| May 12, 2026 | John T. Treace | Buy | 43,000 | $2.17 |
TMCI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $212.69M | $-59.00M | -0.93 | $-15.97M |
| Dec 31, 2024 | $209.36M | $-55.74M | -0.90 | $-37.17M |
| Dec 31, 2023 | $187.12M | $-49.53M | -0.81 | $-34.58M |
| Dec 31, 2022 | $141.84M | $-42.81M | -0.77 | $-30.65M |
| Dec 31, 2021 | $94.42M | $-20.55M | -0.43 | $-17.19M |
Latest balance sheet: total assets $181.06M, total liabilities $113.32M, cash $12.61M (as of Jun 30, 2026).
TMCI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 7, 2026 | 8-K Item 2.02 (results) | $4.76 |
| May 8, 2026 | 8-K Item 2.02 (results) | $2.01 |
| Apr 9, 2026 | 8-K Item 2.02 (results) | $1.53 |
| Feb 27, 2026 | 8-K Item 2.02 (results) | $1.86 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $2.71 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $6.23 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $5.68 |
| May 8, 2025 | 8-K Item 2.02 (results) | $7.54 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $9.13 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $8.36 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $5.76 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on TMCI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.